Short Summary
Mercedes‑Benz has filed an IPR petition seeking cancellation of all 20 claims of U.S. Patent 9,045,101, arguing they are anticipated or obvious over existing driver‑authentication and vehicle‑monitoring technologies. The petition cites multiple prior‑art references and argues that discretionary factors favor institution.
Detailed Summary
In a corrected petition for inter partes review, Mercedes‑Benz Group AG challenges claims 1‑20 of U.S. Patent No. 9,045,101, which covers a vehicle driver‑authentication and monitoring system. The petitioner asserts six grounds of unpatentability, relying on statutes 102 and 103, and cites prior‑art references including Murphy (U.S. Patent 6,225,890), Schanz (German publication DE10323723A1), Petrik (U.S. application 2007/0168125 A1), and Benco (U.S. application 2008/0136611A1). Each ground targets either all claims or claim 10 specifically. The petition further argues that discretionary considerations under §§314(a) and 325(d) strongly favor institution, referencing the Fintiv factors and the Advanced Bionics framework. No claim constructions or expert testimonies are presented, and the proceeding is currently at the petition stage awaiting the Board’s institution decision.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Mercedes-Benz Group AG et al. vs Phelan Group, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Databricks, Inc.vsByteWeavr, LLC
Databricks and ByteWeavr reached a settlement that led the PTAB to terminate the IPR concerning patent 8,275,827 before any merits were decided. The settlement agreement was kept confidential under Board rules.
HIKMA PHARMACEUTICALS USA INC.vsAxsome Malta Ltd. et al.
Hikma Pharmaceuticals filed a joint motion with Axsome Malta to terminate IPR2024‑01418 after reaching a confidential settlement, resulting in dismissal of the petition before institution.
Google LLC et al.vsMullen Industries LLC
The PTAB denied Google’s request to rehear its discretionary denial of institution in an IPR against Mullen Industries’ OLED display patent, citing a parallel district‑court trial and weak petition merits. The decision upholds the Director’s discretion under 35 U.S.C. § 314(d).
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB granted Imperative Care’s petition to institute inter partes review of Inari Medical’s hemostasis‑valve patent, finding a reasonable likelihood of unpatentability for claims 1‑9.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
The PTAB held that all 35 claims of Netlist’s ’339 memory‑module patent are obvious over the Ellsberry and Halbert references. Samsung and its co‑petitioners prevailed, resulting in the patent’s claims being invalidated.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.